Triptolide as a potential chemotherapy for pediatric adrenocortical tumors (2024)
- Authors:
- USP affiliated authors: QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; TONE, LUIZ GONZAGA - FMRP ; VALERA, ELVIS TERCI - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; RAMOS, MILENA DA SILVA - FMRP ; BAPTISTELLA, MARIANE MINUSSI - FMRP ; CANDIDO, MARINA FERREIRA - FMRP ; XAVIER, ALCIDES EUZEBIO TAVARES - FMRP
- Unidade: FMRP
- Subjects: CARCINOMA; CÓRTEX ADRENAL; GLÂNDULAS SUPRARRENAIS
- Keywords: Adrenocortical tumors; Triptolide; NF-kB pathway
- Agências de fomento:
- Language: Português
- Imprenta:
- Publisher: Sociedade Brasileira de Genética (SBG)
- Publisher place: Ribeirão Preto
- Date published: 2024
- Source:
- Título: Resumos (e-Book )
- Conference titles: International Congress of the Brazilian Genetics Society
-
ABNT
RAMOS, Milena da Silva et al. Triptolide as a potential chemotherapy for pediatric adrenocortical tumors. 2024, Anais.. Ribeirão Preto: Sociedade Brasileira de Genética (SBG), 2024. Disponível em: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf. Acesso em: 29 jan. 2026. -
APA
Ramos, M. da S., Baptistella, M. M., Candido, M. F., Xavier, A. E. T., Queiroz, R. G. de P., Tone, L. G., et al. (2024). Triptolide as a potential chemotherapy for pediatric adrenocortical tumors. In Resumos (e-Book ). Ribeirão Preto: Sociedade Brasileira de Genética (SBG). Recuperado de https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf -
NLM
Ramos M da S, Baptistella MM, Candido MF, Xavier AET, Queiroz RG de P, Tone LG, Valera ET, Scrideli CA. Triptolide as a potential chemotherapy for pediatric adrenocortical tumors [Internet]. Resumos (e-Book ). 2024 ;[citado 2026 jan. 29 ] Available from: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf -
Vancouver
Ramos M da S, Baptistella MM, Candido MF, Xavier AET, Queiroz RG de P, Tone LG, Valera ET, Scrideli CA. Triptolide as a potential chemotherapy for pediatric adrenocortical tumors [Internet]. Resumos (e-Book ). 2024 ;[citado 2026 jan. 29 ] Available from: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf - Identification of FDA: approved and blood-brain barrierpenetrating drugs for novel therapies in glioblastoma
- Exploring blood-brain barrier-crossing drugs for the identification of novel therapies in pediatric medulloblastoma
- The TK1 gene as a potential prognostic marker and its correlation with immune cell infiltrates in adrenocortical carcinoma: in silico analyses
- Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a brasilian population
- Study adrenocortical tumors in children and adolescent by technique comparative genomic hybridization (CGH)
- Role of SHOC2 gene in the chemotherapy sensibility process in childhood acute lymphoblastic leukemia
- HDAC9 over-expression correlated with adverse prognosis in acute lymphoblastic leukemia
- A simplified PCR approach for minimal residual disease (MDR) detection at early treatment points stratifies children with acute lymphoblastic leukemia (ALL) into good and poor outcome groups
- mRNA expression of NMP2 and MMP9 and TIMP1 and TIMP2 in childhood all: potential role of TIMP1 as an adverse prognostic factor
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
